Entinostat is a type of medicine that belongs to a class of drugs known as histone deacetylase (HDAC) inhibitors. This type of drug is used to treat certain types of cancer, such as advanced breast cancer and non-small cell lung cancer. It works by blocking certain proteins that help cancer cells survive and spread. By blocking these proteins, entinostat can cause cancer cells to die. It is typically given as a pill, which can be taken with or without food.
Entinostat is an investigational drug, meaning it's still undergoing clinical trials to assess its safety and efficacy for various medical conditions. Here's what we know about it so far:
Type of Drug:
- Entinostat belongs to a class of drugs called histone deacetylase (HDAC) inhibitors.
How it Works:
- Inside the cells, DNA is tightly coiled around proteins called histones. This packaging regulates gene activity.
- HDACs are enzymes that remove acetyl groups from histones. This tightens the DNA packaging, making it harder for genes to be turned on.
- Entinostat inhibits HDAC activity, leading to increased acetylation of histones. This loosens the DNA packaging and allows for greater gene expression.
Potential Uses:
The primary focus of research on Entinostat is its potential as a cancer treatment. Here's why:
- Abnormal gene expression is a hallmark of cancer. By influencing gene activity through HDAC inhibition, Entinostat may be able to:
- Suppress the growth and proliferation of cancer cells.
- Induce cancer cell death (apoptosis).
Current Status:
- Entinostat has been investigated for various cancers, including non-small cell lung cancer and hormone receptor-positive breast cancer.
- Clinical trials are ongoing to determine its effectiveness and optimal use.
Important to Note:
- Entinostat is not yet an approved treatment for any medical condition.
- More research is needed to fully understand its safety and efficacy profile.
Here are some additional points to consider:
- Entinostat is typically administered orally.
- Potential side effects are still under investigation but may include fatigue, nausea, vomiting, diarrhea, and low blood cell counts.
- As with any medication, Entinostat may interact with other drugs. It's crucial to disclose your complete medical history and current medications to your doctor if Entinostat is being considered for you in a clinical trial setting.
Remember, this information is for educational purposes only and shouldn't replace consulting a healthcare professional. If you have any questions about Entinostat, talk to your doctor, especially if you're involved in a clinical trial.